Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2010
10/07/2010CA2757291A1 Medical composition for treatment or prophylaxis of glaucoma
10/07/2010CA2757016A1 Radiolabelling reagents and methods
10/06/2010EP2236505A1 Acylated aminopyridines and pyridazines as insecticides
10/06/2010EP2236498A1 Phenyl acetamide derivative
10/06/2010EP2236485A1 Organic material containing oligophenylene skeleton and light-emitting device using the same
10/06/2010EP2235014A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/06/2010EP2235001A1 4-pyridinone compounds and their use for cancer
10/06/2010EP2234993A1 Bis- (sulf onylamino) derivatives for use in therapy
10/06/2010EP2234978A1 Carbamoyl compounds as dgat1 inhibitors 190
10/06/2010EP2234977A1 Viral polymerase inhibitors
10/06/2010EP2234976A1 Novel pyrazole-substituted arylamides
10/06/2010EP1296951B1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis
10/06/2010CN101855210A Amides useful as inhibitors of voltage-gated sodium channels
10/06/2010CN101855209A Alkylsulfone derivative
10/06/2010CN101855208A 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
10/06/2010CN101855199A Tricyclic amide compound
10/06/2010CN101851255A Method for producing ruthenium complex
10/06/2010CN101851199A Substituted piperazine N-ethyl sulfonamide derivative and preparation and application thereof
10/06/2010CN101851194A Method for preparing nicotinamide
10/06/2010CN101851193A Preparation method of 4-trifluoromethyl nicotinic acid
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101850270A Application of central palladium phosphine ferrocenylimine complex for catalyzing and synthesizing amine-methylated aromatic compound
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/05/2010US7807842 Synthesis of tetracyclines and analogues thereof
10/05/2010US7807838 Methods for the preparation of HCV polymerase inhibitors
10/05/2010US7807703 Herbicides; pesticides
10/05/2010US7807701 Dibenzylamine compounds and pharmaceutical use thereof
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807682 Pyridyl cyanoguanidine compounds
10/05/2010US7807677 1-[N'-[(R)-4-Hydroxy-4-((1S,2R)-2-hydroxy-indan-1-yl]carbamoyl)-5-phenyl-pentyl]-N'-(4-pyridin-4-yl-benzyl)-hydrazinocarbonyl]-2,2-dimethyl-propyl-carbamic acid methyl ester; effective against strains resistant to squinavir, ritonavir, and indinavir; improved bioavailability
10/05/2010US7807669 Peroxisome proliferator-activated receptor type gamma (PPAR- gamma) modulators such as (S)-3-{3'-[(benzoylmethylamino)methyl]biphenyl-4-yl}-2-(1-methyl-3-oxo-3-phenylpropenylamino)propionic acid, suited for use in dermatology, immunology, cardiovascular diseases and/or hyperlipemia
09/2010
09/30/2010WO2010110409A1 Process for producing pyrone and pyridone derivatives
09/30/2010WO2010110231A1 Substituted 3-hydroxy-4-pyridone derivative
09/30/2010WO2010109123A1 Anticancer derivatives, preparation thereof, and therapeutic use thereof
09/30/2010WO2010109122A1 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
09/30/2010WO2010109115A1 Anticancer compounds, preparation thereof, and therapeutic use thereof
09/30/2010WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108856A1 Leukotriene b4 inhibitors
09/30/2010WO2010108652A1 Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100249196 Novel Salt Forms Of (2S)-(4E)-N-Methyl-5-[3-(5-Isopropoxypyridin)yl]-4-Penten 2-Amine
09/30/2010US20100249187 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249165 Pdz domain modulators
09/30/2010US20100249147 Sulfonyl-substituted 6-membered ring derivative
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249135 Sulfonamides and their use as a medicament
09/30/2010US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/30/2010US20100249077 Pyridylmethyl-Sulfonamide Compounds
09/30/2010US20100249024 Cetp inhibitors
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010US20100247461 Anti-inflammatory complexes
09/30/2010US20100247439 Dendritic nano-antioxidants
09/30/2010US20100244014 Electroluminescent metal complexes with triazoles and benzotriazoles
09/30/2010DE19840447B4 Fluorierte Derivate des Indans und ihre Verwendung in flüssigkristallinen Mischungen Fluorinated derivatives of indane and their use in liquid crystal mixtures
09/30/2010CA2756566A1 Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors
09/30/2010CA2756152A1 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
09/30/2010CA2756099A1 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
09/30/2010CA2755348A1 Antiviral compounds and uses thereof
09/30/2010CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010CA2747327A1 Leukotriene b4 inhibitors
09/29/2010EP2233470A1 Histamine H3 receptor antagonists
09/29/2010EP2231680A2 Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof
09/29/2010EP2231612A1 Polymorph form iii of sorafenib tosylate, sorafenib tosylate methanol solvate and sorafenib tosylate ethanol solvate, and processes for preparation thereof
09/29/2010EP2231611A1 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
09/29/2010EP2231610A1 Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
09/29/2010EP2231609A1 Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
09/29/2010EP2231608A1 Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
09/29/2010EP2231606A2 Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids
09/29/2010EP2231603A1 Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof
09/29/2010EP2231602A1 Gamma secretase modulators
09/29/2010EP2231137A1 Method of modulating membrane potential of a cell
09/29/2010EP1638928B1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
09/29/2010CN1931842B Preparation process of tenatoprazole and its starting compound
09/29/2010CN1865259B Process for preparing piperidine derivative
09/29/2010CN1821217B Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
09/29/2010CN1794987B Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
09/29/2010CN1753673B Prodrugs of GABA analogs, compositions and uses thereof
09/29/2010CN101848894A New anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution
09/29/2010CN101848893A 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
09/29/2010CN101845015A Refining separation and drying method of 4-dimethylamino naphthyridine
09/29/2010CN101845014A Method for reducing heteroaromatic carboxylic acid into heteroaromatic alcohol
09/29/2010CN101293866B Bisphenol monomer containing pyridine group and preparation method thereof
09/29/2010CN101061106B Potentiators of glutamate receptors
09/29/2010CN101035762B Alkil-pyridines as 11-beta inhibitors for diabetes
09/28/2010US7804592 using a noble metal compound having N,N,N'-tri(2-pyridylmethyl)-N'-[5-N''-(2-aminoethyl)carbamoyl-2-pyridylmethyl]-1,3-diamino-propane-2-ol zinc complex as substituent for detecting phosphorylation of peptide in a sample; Raman spectroscopy
09/28/2010US7803947 producing an O-aryl N-(6-alkoxy-2-pyridyl)-N-alkylthiocarbamate by treating a phenol with a base in a solvent, adding thereto an alkali metal salt of N-(6-alkoxy-2-pyridyl)-N-alkyldithiocarbamic acid and a halomethane; safer and has fewer steps than conventional production methods
09/28/2010US7803946 hosts report binding events by exhibiting altered spectroscopic properties, such as different fluorescent emission spectra
09/28/2010US7803841 EP2 receptor agonists
09/28/2010US7803818 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridine-2-one; antagonistic action against AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor and/or inhibitory action against kainate receptor prophylactic agent for neurodegenerative diseases
09/28/2010US7803800 Histone deacetylases inhibitors
09/28/2010CA2574875C Aryl-pyridine derivatives as 11-beta hsd1 inhibitors
09/28/2010CA2553578C Process for halomethyl ethers of hydroxyiminomethyl quaternary pyridinium salts
09/28/2010CA2387016C Acrylamide derivatives as fab i inhibitors
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/28/2010CA2308201C Use of anti-fungal agents for the treatment of fungus-induced mucositis
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 633